Omega-3 supplements do not protect against cardiovascular disease, meta-analysis shows
A meta-analysis of 79 trials showed that increasing long-chain omega-3 had little or no effect on death from all causes, cardiovascular deaths, cardiovascular events, coronary heart disease deaths, stroke or arrhythmia.
Increasing omega-3 intake does not benefit cardiovascular health, show the results of a recent Cochrane review.
The research included 79 randomised controlled trials lasting at least 12 months, most of which involved supplementation with long-chain omega-3, while others involved dietary advice to increase fatty acid intake. In total, the data included 112,059 participants.
A meta-analysis found little or no effect of increasing long-chain omega-3 intake on death from all causes, cardiovascular deaths, cardiovascular events, coronary heart disease (CHD) deaths, stroke or arrhythmia. There was low-quality evidence that eating alpha-linolenic acid-rich (plant-based) foods may slightly reduce cardiovascular events, CHD deaths and arrhythmia.
Lead author Lee Hooper, a reader in research synthesis, nutrition and hydration at Norwich Medical School at the University of East Anglia, said: “We can be confident in the findings of this review, which go against the popular belief that long-chain omega 3 supplements protect the heart.
“This large systematic review included information from many thousands of people over long periods; despite all this information, we don’t see protective effects.”
Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20205377
Recommended from Pharmaceutical Press
Pharmacy Registration Assessment Questions 2 features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own. All questions are in line with current GPhC guidance, enabling you to prepare for the pharmaceutical pre-registration exam with confidence.£35.00Buy now
All you need to know about prescribing or administering drugs via enteral feeding tubes. Over 400 drug monographs as well as facts to inform clinical decision making.£54.00Buy now
Commonly known as the Orange Guide, this book is an essential reference for all involved in the manufacture or distribution of medicines in Europe.£82.00Buy now